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Abstract 
Osteoporosis and associated fractures are major public health concerns, and as 
such, require appropriate large animal models in order to further our 
understanding of this disease. Although sheep appear to be an ideal model with 
which to study bone loss due to estrogen depletion, limited data is available 
concerning the long-term effect of ovariectomy on bone in sheep. The goal of the 
present study was to observe the ovariectomy induced changes in bone mass, 
structure and metabolism in sheep over a period of 18 months. Six ewes were 
ovariectomized (ovx) and compared to an age-matched control group by 
analyzing bone mineral density, trabecular structure, biochemical markers of bone 
formation and resorption, and plasma estrogen levels. Bone loss (13%, p<0.01) 
occurred during the first 4 months after surgery, then stabilized and returned back 
to pre-ovx levels for the remainder of the study. Trabecular architecture was also 
altered and tended towards osteopenia with recovery to baseline values. Marker 
of bone formation and resorption were elevated up to 6 months post ovariectomy 
after which time levels returned to baseline values. Although estradiol-
measurements demonstrated a clear decline following surgical ovariectomy, 
levels returned to normal after 6 months. Therefore, the detrimental effect of 
ovariectomy on sheep bone metabolism seems to be reversible with normal bone 
parameters being re-established within 6 months after surgery. These data seems 
to indicate that the sheep is an inappropriate model for human post-menopausal 
osteoporosis. 
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Introduction 
Due to the dramatic increase in the elderly population and the rise in the incidence 
of fractures, osteoporosis has become a major public health concern [1-3]. Since 
new treatment strategies and better fixation methods in such fragile bones can not 
be developed in vitro, there is a great need for suitable animal models which 
closely simulate osteoporosis in humans [4].  
Various experimental models of human osteoporosis have been described in 
several different species [4]. The ovariectomized rat is probably the most widely 
studied rodent osteoporotic model. This model mimics postmenopausal 
cancellous bone loss over a relatively short time period [5;6]. However, extended 
studies over 12 months have demonstrated increased bone mineral content, bone 
area and body weight, which is not comparable to the human situation [7;8]. 
Furthermore, the lack of the Haversian system in cortical bone, the absence of 
impaired osteoblast function during late stages of estrogen deficiency and the 
absence of multicellular unit-based remodelling in young rats also limits this model 
[9]. An additional requirement of experimental osteoporosis models is the ability to 
assess the performance of surgical implants. Such procedures are clearly 
impractical in the experimental rat model due to limitations in size. The “FDA 
Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Treatment 
of Prevention of Postmenopausal Osteoporosis” recommend agent evaluation in 
two different species including ovariectomised rats and one non-rodent large 
animal model [10]. Although these guidelines primarily pertain to pharmaceutical 
drugs, pre-clinical evaluation is also required for new surgical treatment options. 
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Therefore, there is an obvious need for large as well as small animal models of 
osteoporosis. 
Large animal osteoporosis models include non-human primates, dogs and sheep. 
Monkeys such as baboons and macaques have an advantage over other 
osteoporosis models due to their close physiological resemblance to humans, 
including gastrointestinal tract, endocrine system and bone metabolism [11-13]. 
Female monkeys have hormonal patterns and a monthly cycle very similar to 
those of humans. Aged macaques and baboons experience a similar decline in 
ovarian function and irregular menstrual cycles as in peri- and postmenopausal 
women. However, due to ethical reasons and handling costs, the experimental 
use of these species is rather limited.  
Dogs possess cortical bone with a Haversian system and manifest internal cortical 
and cancellous bone remodelling processes similar to those in humans. Studies 
have evaluated the effects of ovariectomy on histomorphometric variables in 
cancellous and cortical bone in several breeds of dog [14-19]. Although significant 
changes in cancellous bone volume were observed in these studies, the data is 
conflicting and suggests that canine experimental osteoporosis may not be the 
most suitable animal model for studying bone loss following ovariectomy. More 
importantly, fracture rates in aged, sedentary dogs without ovaries and uteri are 
not comparable to those of postmenopausal women [20]. Finally, the emotional 
attachment to dogs, along with the stringent legal housing requirements, 
contributes to the difficulties in using this experimental model of osteoporosis.  
Sheep have been extensively studied as an experimental model of bone disease 
[4]. Bone loss in sheep is associated with estrogen deficiency and their hormone 
profiles are similar to those of women [21-24]. Their size permits the implantation 
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of prosthetics, isolation of large quantities of fluid samples, as well as iliac crest 
biopsies [25]. Although reports have not described consistent decreases in bone 
mineral density or bone mass at different anatomical locations, significant 
changes in these parameters have been demonstrated in distal radius and spine 
[26]. Biochemical markers of bone formation such as bone-specific alkaline 
phosphatase were reported to increase in sheep after ovariectomy [24], indicating 
an increase in bone turnover similar to the human post-menopausal situation. 
However, only a 10% reduction in sheep bone mass has been attained through 
old age or estradiol privation following ovariectomy, while in osteoporotic humans, 
this value is at least four fold higher [27]. Reports describing the long-term effects 
of ovariectomy in sheep are limited and studies have predominantly focused on 
animals post mortem or in large time intervals [22]. Furthermore, the reported 
effects of ovariectomy on estrogen levels in ewes are highly controversial [28;29].  
In the present study, we examine the long-term effects of ovariectomy on bone 
density, structure and metabolism in sheep. Multiple parameters of bone turnover 
including mineral density (pQCT), 3-D trabecular architecture and biochemical 
markers are investigated and their association with estradiol hormone levels 
determined. 
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Materials and methods 
Study design 
The European and Swiss laws on animal experimentation were strictly observed 
during the entire study and the animal research protocol was approved by the 
competent ethical committee. Fourteen female white alpine sheep with mean age 
of 3.1 ± 0.7 years at the beginning of the study were included in this study. They 
were divided into 2 groups based on BMD and body weight, so that there would 
be no statistical differences between the means. Six sheep were ovariectomized 
(ovx), while the others (n=8) were used as a control group (control).  
The sheep were hold in group boxes under standardized conditions and natural 
light, and got their body weight measured weekly. During the entire observation 
period the animals were fed twice daily with silage (1.5 kg/animal*day)(10.3g/kg 
Calcium, 4.1 g/kg phosphorus), hay (0.25 kg/animal*day)(6.3 g/kg Calcium, 2.8 
g/kg phosphorus) and straw as well as water ad libidum. Urine and venous blood 
samples were collected on day 28, 14 and 1 before surgery, and every fourth 
week after surgery for quantification of bone markers and hormones. The BMD 
was measured at distal radius by pQCT 2 weeks before surgery and at 3 months 
intervals after surgery. For micro-CT-measurements, bicortical iliac crest biopsies 
have been taken at the time of the ovariectomy and at 3, 6 and 9 months after 
surgery. The study ended 18 months after surgery. 
Surgical procedures 
In April 2003, 6 ewes (treatment group) were subjected in supine position to 
midventral laparatomy under general anaesthesia with Isofluran (Halocarbon 
Laboratories, River Edge, NJ) and intravenous Temgesic (Buprenorphine HCl 0.3 
Sigrist I et al                                                                                                                             Long-term effect of ovx in sheep 
9 
mg/mL, Reckitt& Colman Pharmaceutics, Hull, UK). Bilateral ovariectomy was 
performed, with care being taken to ligate doubly the ovarian ligament, artery and 
vein. Post-operative pain medication was given as necessary.  
Bicortical transiliacal biopsies were taken under general anaesthesia in all 14 
animals bedded in prone position. To cut them out, a trephine drill (TL 05 trephine 
2.0, external diameter 7.3 mm, internal diameter 6.4 mm) under constant irrigation 
has been used. The length of the biopsies was given by anatomical conditions, as 
the transfixion was made 1 cm below the iliac crest, alternating medial and lateral 
from the spina iliaca, either on the right or on the left pelvic bone.  
BMD-measurement 
The bone mineral density (BMD in grams per cubic centimetre) was measured by 
pQCT using a Densiscan 1000 (SCANCO Medical AG, Bassersdorf, Switzerland). 
The distal radius of both sides was examined. To avoid artefacts caused by 
movement, the measurements were performed under general anaesthesia. After 
fixation of the limb in the CT scanner, a projectional scout view was accomplished 
to determine the axial position. The joint surface was defined as starting point 
using a reference line. A highly filtered low-energy X-ray source was used to 
enhance the bone contrast. The effective energy of the X-ray beam was always 
set to forty kilo-electron volts and 0.5 mill modus. The slice thickness was 1 mm 
and a matrix of 512x512 pixels was used resulting in a spatial resolution of 
290x290µm. Ten consecutive slices were obtained, and a contour surrounding the 
radius on each cross section was detected. The µ50-CT value was calculated 
using the interior 50% of a section to ensure that only cancellous bone was 
measured.  
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Structural parameters in micro-CT 
After harvesting transiliacal biopsies and immediate fixation in 70% Ethanol, 
micro-CT scans using MicroCT 40 (SCANCO Medical AG, Bassersdorf, 
Switzerland) were performed. This system is working with a fan-beam in a 
multislice mode. An X-ray tube with microfocus is used as source, and a CCD-
array as detector. The spatial resolution was 22 µm in all directions. The volume 
of interest included a cube with a side length of 4 mm and was displayed in 
14x14x14 cubic micron voxels. Bone volume/ total volume (BV/TV), trabecular 
thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp) and 
the degree of anisotropy (DA) were measured.  
Bone markers 
Venous blood samples were allowed to clot for 30 minutes at room temperature. 
The serum then was collected by centrifugation (30 minutes at 4000 rpm, room 
temperature). Serum samples were stored at -20°C until assay. 
Bone specific alkaline phosphatase (bALP) 
Serum bALP levels were determined by ELISA, using the METRA BAP EIA kit 
(TECOmedical AG,5034 Suhr CH). Principle of the procedure: Metra BAP is an 
immunoassay in a microtiter strip format utilizing a monoclonal anti-BAP antibody 
coated on the strip to capture BAP in the sample. The enzyme activity of the 
captured BAP is detected with a pNPP substrate. Control samples were within the 
given range (14.9 and 15.4 U/L for low control (range 9.8 – 21.1 U/L); 64.3 and 
86.6 U/L for high control (range 62.0 – 97.2U/L). 
Deoxypyridinoline (DPD) crosslinks 
As no reliable method to measure DPD in sheep urine was found except for the 
HPLC method, which is very time-consuming and laborious for such a big amount 
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of samples, the METRA DPD ELISA has been used. Finally HPLC and DPD 
ELISA have been compared in a parallel measurement with a few samples 
showing significant relationship. The METRA DPD ELISA is a competitive enzyme 
immunoassay (TECOmedical AG, Suhr CH). DPD in the sample competes with 
conjugated DPD-alkaline phosphatase for the antibody and the reaction is 
detected with a pNPP substrate. Control samples were measured as 16.8 and 
15.1 nmol/L for low control (range 13.1 – 21.4 nmol/L) and 86.2 and 92.2 nmol/L 
for high control (range: 71.0 -115.9 nmol/L). The analysis using the ELISA-method 
was verified by high pressure liquid chromatographie. The DPD results were 
corrected for urinary concentration by creatinine, which has been quantified by the 
METRA Creatinine assay from TECOmedical AG (Suhr CH) basing on a 
quantitative, colorimetric assay (modified Jaffé method). 
Pyridinoline (PYD) 
For a quantitative measure of the excretion of pyridinoline crosslinks in serum, the 
METRA Serum PYD EIA kit (TECOmedical AG, Suhr CH), a competitive enzyme 
immunoassay in a microtiter plate, was used. PYD in the samples or standards 
competes with PYD immobilized on the plate for polyclonal rabbit anti-PYD 
antibody. Bound antibody is detected by goat anti-rabbit antibody conjugated to 
alkaline phosphatase and the reaction is detected with pNPP substrate. Control 
samples were measured as 2.0 and 2.3 nmol/L for low control (range 1.6. – 2.6 
nmol/L) and 6.5 and 8.1 nmol/L for high control (range: 6.3 - 10.4)nmol/L). 
Hormone Estradiol (E2) 
Serum estradiol levels were determined with the 17β-Estradiol ELISA from IBL 
Hamburg (Germany). Principle of the procedure: an unknown amount of estradiol 
present in the sample and a fixed amount of estradiol conjugated with horse-
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radish peroxidase compete for the binding sites of a polyclonal estradiol antiserum 
coated onto the wells. Manufacturer´s protocol was followed as described and 
samples were assayed in duplicates. The intra- and inter-assay coefficients of 
variation and the limits of detection were 4.9-5.9%, 6.2-10.1% and 3 pg/ml 
respectively. All values below the detectable limit were recorded as 0 pg/ml. The 
controls were within the given ranges (low control: 115 and 101 pg/ml vs. 50 – 
130 pg/ml, high control: 384 and 218 pg/m vs. 168 - 432 pg/ml). 
In addition to the method mentioned above, the serum estradiol-levels were 
determined at an external, independent laboratory (Diavet, Bäch CH) with 
extensive experiences in biochemical veterinary diagnostics. 17β-Estradiol was 
measured using an electrochemi-luminescent-sandwich-ELISA. 
Statistical analysis 
Statistical analysis was performed using SPSS software package (SPSS Inc., 
Chicago, USA). Results are presented in mean ± standard deviation. For 
comparison between the groups analysis of variance (ANOVA) was used for bone 
markers and non-parametric testing (Mann-Whitney test) was used for others. The 
level of significance was set at 0.05. 
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Results 
All animals tolerated the surgical procedures well without any side effects. One 
ovariectomized sheep died at 16 months of observation due to oesophageal 
infection which was not related to the treatment methods of this study. During the 
entire observation period, the mean body weight was 67.6 ± 4.5 kg for control and 
67.5 ± 5.3 kg for ovx. The body weight fluctuated over time but the individual 
changes were below 10% in all sheep. No differences at any time point were 
found between the groups. 
Bone Mineral Density 
The cancellous bone mineral density at distal radius in control sheep remained 
constant with time at ~ 0.71 g/cm3 out to 17 months. The course of cancellous 
bone mineral density in the control group showed small changes with a slight 
decrease at the beginning of the study followed by minimal increase at 15 months. 
All changes were not significant compared to baseline. Ovx sheep exhibited an 
rapid, initial phase of cancellous bone loss of -12.7% (p=0.008) between 0 and 4 
months post ovariectomy. Then, a period of relative stabilisation of cancellous 
bone volume at this osteopenic level occurred between 4 to 12 months, followed 
by a phase of minimal increases in bone mass until 17 months post surgery 
(Figure 1).  
Static bone morphometry and trabecular architecture by micro-CT 
The changes of the structural parameter in cancellous bone of the iliac crest are 
shown in Figure 2. Following ovariectomy, the parameters bone volume to total 
volume (BV/TV) (3 months: p=0.007, 6 months p=0.010) and trabecular thickness 
(3 months: p=0.010) are decreasing up to 6 months with a subsequent increase to 
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baseline values. Trabecular number and separation did not change during the 
observation period.  
Bone markers 
Figure 3 depicts the serum bALP patterns over the first phase (6 months) of 
observation. The control group shows seasonal variations which have to be 
considered, while in the ovx group, there is a 50% elevation of bALP at 2 months 
after ovariectomy (p=0.015). In this group bALP decreases until fall towards 
baseline values, but still elevated at 6 months compared to control group 
(p=0.006). No differences were found at any later time point. Increased levels of 
serum pyridinoline were found at 2 months after ovariectomy only (p=0.005) and 
no differences between the groups were determined at any later time point until 
18 months. The urine deoxypyridinoline values did not show significant 
differences between the controls and the ovariectomised sheep.  
Estradiol 
17ß-Estradiol decreased 3 months after ovariectomy (p=0.021) in the treated 
group to values below the detection limit (3pg/mL) and then increased massively 
in both groups. The developing of the control values showed a period of anoestrus 
in May and June, followed by the breeding season in fall and winter with higher 
serum estradiol levels (mean 20.8 pg/mL) (Figure 4A). With the exception of 
significant decrease of estrogen levels following ovariectomy no differences were 
found between the two groups (Figure 4B). The data were validated using a 
different method at an independent laboratory. 
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Discussion 
This study investigated the long term effect of ovariectomy on ewe, demonstrating 
an early bone loss (-13%) followed by rebound effect in the later phase of the 
observation period.  
To investigate postmenopausal bone loss and its consequences, there is a great 
need to develop an osteoporotic animal model for the testing of orthopedic 
implants as well as for pharmacological research on prevention and treatment. 
Sheep show several advantages as a model for osteoporosis: easy handling and 
keeping, availability in large numbers so that large-scale studies are possible, 
implant dimensions comparable to human implants, similar metabolic rate and 
bone remodelling process as humans [4;25], and osteopenic response to 
menopause simulating manipulations [24]. 
The present study evaluated the effect of ovariectomy on bone metabolism in 
sheep by determining bone mass, bone micro architecture, biochemical markers 
of bone formation and resorption as well as estradiol. Dietary effects were 
excluded by standardized feeding and a bias due to physical activity was 
constrained by single group husbandry. The surgery was performed in spring 
when lowest bone mass is usually observed during the season to minimize 
seasonal influences on the bone loss following ovariectomy. As ovariectomy is a 
standard procedure in our institution [30], the authors omitted a sham group to 
avoid the use of more animals in the study as requested by the ethical committee, 
although all sheep had bilateral transiliacal biopsies. Therefore, a limitation of this 
study is the lack of a true sham operated control group since the effect of 
ovariectomy can not be distinguished from any influences of wound healing. Prior 
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studies have demonstrated an increased bone turnover following ovariectomy in 
sheep leading to a loss of bone mass of approximately 10%. Geusens et al. 
observed a non significant bone loss of -3 to -9 % at the femur [31], Lill et al. 
measured a decrease of 5.5% of BMD at distal radius in ovariectomized sheep 
with a calcium-wasting diet [30], while several publications from Turner et al. 
report about a decline of BMD from 3 to 8 % [20;24;25]. However, it has not been 
determined whether these small ruminants experience a short-term effect of 
ovariectomy, or if they develop osteoporosis over a longer period of time as it is 
the case in humans. In the present study, the great majority of bone loss (-13%) 
occurred during the first 4 months post ovariectomy. This initial, rapid phase was 
followed by a period between 7 to 9 months during which cancellous bone mass 
appeared to stabilize at the mentioned osteopenic level. Afterwards the bone 
mass seemed to increase towards baseline values. The changes of bone mass in 
control group are due to seasonal changes [20]. During the period between 7 and 
14 months, both bone loss and bone turnover subsided. The rapid, initial phase of 
bone loss is coincident with the maximal increase in bone turnover, which 
confirms previously reported studies [32]. These data clearly suggest short term 
effects on bone mass in ovariectomized ewes.  
Several other studies have been determining BMD using DXA, either on spine, 
femur, calcaneus or distal radius, with different results [23;24]. BMD 
measurements by DXA (a two dimensional technique) are affected by skeletal 
size, and changes in density may be obscured by the mass of wool, soiling of the 
skin and subcutaneous fat layer [33]. Measurement of volumetric BMD by pQCT 
though is advantageous as it is independent of skeletal size; it allows for selective 
measurement of cortical and trabecular density and bone area [34]. 
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As many recent studies have shown that BMD alone is not sufficient to determine 
the strength of cancellous bone, we also looked at static bone morphometry and 
trabecular architecture using microcomputed tomography [35;36]. Those 
parameters are important factors in determining bone strength and the risk of 
fractures. Micro computed tomography (micro-CT) enables the complete three-
dimensional digitisation of small specimens at resolutions of between 10 and 75 
microns. It has the ability to provide quantifiable measures of bone architecture 
and morphology in three dimensions, giving the exact structure of a bone biopsie. 
The decrease in BV/TV goes along with a decrease of trabecular thickness 
indicating. Although the loss of bone mass in post-menopausal women is driven 
by decrease of trabecular number [37], the results are similar to previous reports 
[26] and indicate the increased bone resorption and thinning of the trabecular 
structures.  
Bone-specific alkaline phosphatase (bALP) has been analysed to measure bone 
formation. While the control group shows seasonal fluctuations, an elevation of 
serum bALP-levels until 6 months post ovariectomy can be observed indicating an 
increased bone turnover. No differences between the groups were observed at 
any time point later than six months. Turner et al. [24] as well as Chavassieux et 
al. [21] also describe a high bone turnover after ovariectomy. Similar to our results 
a trend towards decreasing levels until the end of the study (6 months) can be 
found. However in both publications, the seasonal timepoint of the ovariectomy is 
unknown. 
To show bone resorption, the pyridinoline crosslinks deoxypyridinoline (DPD) and 
pyridinoline (PYD) have been quantified. Those crosslinks are formed during the 
process of collagen maturation between the chains, and as bone collagen 
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undergoes a higher turnover rate than other tissue sources of collagen, they are 
specific markers for bone resorption. We found increased levels of bone 
resorption marker at 2 months after ovariectomy only. Chavassieux et al. [21] 
observed the highest increase of type 1 collagen C-telopeptide at 3 months after 
ovariectomy.  
By removing the ovaries, the major source of estrogens is eliminated to simulate 
as much as possible the situation after menopause in women. Very few authors of 
studies about ovariectomy have been testing the estradiol levels of the animals 
after operation. Johnson et al. writes that ovariectomy does not totally eliminate 
17-β-estradiol synthesis in sheep – values between 4 and 6 pg/mL- [28], while 
Karsch et al. postulates that serum estradiol concentrations in intact anestrous 
ewes averages 1 pg/mL, and that estradiol levels in ovariectomized animals are 
well below the limit of detection of any biochemical assay [29]. As the opinions 
over this topic are divergent and not much literature can be found, estradiol has 
been quantified in all animals of this study. The results show a significant drop in 
systemic estrogen levels due to ovariectomy followed by increased values without 
differences to the control group. These data highly suggest the presence of non-
ovarian estradiol generation in ovariectomized animals. While the ovaries are the 
principal source of systemic estrogen in the pre-menopausal non-pregnant 
woman, estrogen biosynthesis beyond menopause is mainly peripheral, through 
conversion of androstendione or C19 steroids from the adrenal cortex. Other 
major sites of estrogen production like adipose tissue and skin, muscle and others 
have the capacity to convert C19 steroids to C18 steroids, but as they lack the 
ability to synthesize C19 precursors, they are dependent on circulating precursor 
C19 steroids for estrogen biosynthesis [38;39]. Sheep somehow seem to 
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compensate particularly well the estrogen deficiency, which probably is one of the 
reasons why ovariectomy only causes slight effects on ovine bone [30]. Further 
investigations are needed to determine the source of extragonadal extrogen. The 
ovariectomized sheep still might become a large animal model of postmenopausal 
osteoporosis, but reduction of non-ovarian estrogen production using aromatase 
inhibitors is indicated. Contrary to glucocorticoid excess, this inhibitor would 
simulate perfectly the mechanism of bone loss in postmenopausal women. In a 
study of Chavassieux, the administration of Lentaron, a specific inhibitor of the 
peripheral aromatase, during 6 months tended to amplify slightly the effects of 
ovariectomy on bone markers [21]. Because of seasonal variations and calcium 
intake, experiments in sheep should include all four seasons to minimize the 
seasonal fluctuations, and a calcium-wasting diet [25].  
In summary, this study used a large variety of assessment methods to evaluate 
the long-term effect of ovariectomy in sheep in order to establish a large animal 
model of osteoporosis. Ovariectomy induced bone loss leading to decreased bone 
mineral density (-13%) and deterioration of microarchitecture. However, the 
destructive effect was limited to a few months and a rebound was observed in all 
treated animals. Our results suggest a short-term bone loss after ovariectomy in 
sheep probably due to extra-gonadal estrogen production. These data seems to 
indicate that ovariectomy in sheep does not simulate post-menopausal 
osteoporosis and are therefore not suitable for long term investigations.  
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Figure 1 
 
 
 
 
 
 
 
 
 
Figure 1: Cancellous bone mineral density at distal radius in control and 
ovariectomized sheep. Values are expressed as changes relative to baseline. **= 
p<0.01 
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Structural parameters of cancellous bone at iliac crest biopsies in 
ovariectomized and control sheep. (BV/TV = bone volume / total volume; Tb.Th = 
trabecular thickness; Tb.Sp = trabecular separation). *= p<0.05; **= p<0.01. 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Marker of bone formation (A: serum bone alkaline phosphatase (bALP)) 
and resorption (B: serum pyridinoline (PYD) and C: urine deoxypyridinoline 
(DPD)). Values are expressed as changes relative to baseline (%). *= p<0.05; **= 
p<0.01. 
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Figure 4 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Serum levels of 17ß-estrogen over the course of 12 months (A) 
presented as changes relative to baseline values. At the end of the study estrogen 
was determined at short term intervals (B). *= p<0.05 
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